1604 Organometallics, Vol. 18, No. 9, 1999
McGuinness et al.
P d (tm iy)2(TCNE) (3). This compound was prepared in the
same manner as for 2 (from 228 mg, 0.665 mmol of Pd(COD)-
(TCNE) and 166 mg, 1.34 mmol of tmiy) except for a modified
workup: approximately half of the THF was removed in vacuo
and 10 mL of ether added to complete precipitation. The solid
was collected by filtration, washed with ether (3 × 10 mL),
and dried in vacuo to yield an orange powder. Yield: 273 mg
(85%). Anal. Calcd for C20H24N8Pd: C, 49.75; H, 5.01; N, 23.20.
Found: C, 49.53; H, 4.81; N, 23.08. MS (LSIMS; m/z): 965,
[2M - H]+ (3%); 605, [M - H + (tmiy)]+ (8%); 481, [M - H]+
(40%); 354, [M - (TCNE)]+ (100%). 1H NMR (400 MHz,
CD2Cl2): δ 3.72 (s, 12H, NCH3), 2.11 (s, 12H, CCH3). 13C CP/
MAS NMR: δ 126.3 (CdCtmiy), 35.2 (NCH3), 8.6 (CCH3). IR
(KBr): 2208, 2122 cm-1 (ν(CN)).
complete precipitation. The solvent was decanted off and the
powder washed twice with acetone/ether (1 mL/6 mL) and
again with 15 mL of ether. Drying in vacuo gave an off-white
powder. Yield: 46 mg (51%). Anal. Calcd for C20H28N5O2IPd‚
0.1(acetone) (indicated by NMR): C, 40.00; H, 4.73; N, 11.49.
Found: C, 40.01; H, 4.48; N, 11.05. MS (LSIMS; m/z): 604,
mixed cluster [MH]+ and [M - I + tmiy]+ (14%); 480, mixed
cluster [M - I]+ and [Pd(tmiy)3]+ (6%); 354, [Pd(tmiy)2]+ (11%);
246, [2-(4-nitrophenyl)-1,3,4,5-tetramethylimidazolium]+ (100%).
1H NMR (200 MHz, CD2Cl2): δ 7.62 (d, J ) 9 Hz, 2H, Ph H),
7.42 (d, J ) 9 Hz, 2H, Ph H), 3.87 (s, 12H, NCH3), 2.04 (s,
12H, CCH3). 13C NMR (100 MHz, CD2Cl2): δ 175.6 (NCN),
163.9 (CNO2), 136.6 (PhC), 132.5 (PhC), 124.4 (CdCtmiy), 119.4
(PhC), 34.6 (NCH3), 8.4 (CCH3). IR (KBr): 1652, 1335 cm-1
(ν(NO2)). In DCM solution 6 was allowed to fully decompose
and found to consist of the 2-(4-nitrophenyl)-1,3,4,5-tetra-
methylimidazolium ion and other unidentified product(s) from
the second carbene moiety. MS (LSIMS; m/z): 246, [M]+
Rea ction of 2 w ith P h en yl Iod id e. In a typical experi-
ment Pd(tmiy)2(MAH) (91 mg, 0.20 mmol) was dissolved in
15 mL of THF and phenyl iodide (23 µL, 0.21 mmol) syringed
in. The solution was heated to near reflux for 30 min, during
which time Pd0 deposits form; these were cooled and filtered
through Celite to yield a homogeneous yellow solution. Re-
moval of the solvent in vacuo led to a mixture of yellow and
white solids. The product was washed with 3 mL of THF to
leave a white solid that was composed mainly of Pd(tmiy)2-
(Ph)I (4) with some 2-phenyl-1,3,4,5-tetramethylimidazolium
iodide. MS (LSIMS; m/z): 605, [M - Ph + tmiy]+ (5%); 555,
[M - I + tmiy]+ (2.6%); 481, [M - Ph]+ (2.2%); 431, [M - I]+
(1.8%); 354, [M - PhI]+ (4%); 201, [2-phenyl-1,3,4,5-tetra-
methylimidazolium]+ (100%); 125, [tmiyH]+ (68%). 1H NMR
of 4 (200 MHz, DMSO-d6): δ 7.21-6.60 (m, br, 5H, Ph H), 3.86
(s, br, 12H, NCH3), 2.07 (s, br, 12H, CCH3). 13C NMR of 4 (100
MHz, DMSO-d6): δ 167.1 (NCN), 136.2, 134.8, 130.6, 129.5
(PhC), 125.8 (CdC), 34.6 (NCH3), 8.5 (CCH3). The THF
washings were found to contain a mixture of the starting
complex, Pd(tmiy)2I2 (5), the imidazolium salt, and some
oxidative addition product 4. The ratio of products obtained
depended on the conditions employed. Thus, when the system
was heated for a prolonged time (ca. 2 h), the major product
was 5 along with the imidazolium salt. Complex 5 was
1
(100%); 125, [tmiyH]+ (41%). H NMR (200 MHz, CD2Cl2): δ
8.47 (d, J ) 9 Hz, 2H, Ph H), 8.14 (d, J ) 9 Hz, 2H, Ph H),
3.62 (s, 6H, NCH3), 2.36 (s, 6H, CCH3).
P d (t m iy)2Br 2 (7). To a DCM (20 mL) suspension of Pd-
(tmiy)2(TCNE) (108 mg, 0.22 mmol) was added bromine (12
µL, 0.23 mmol) dropwise and the solution stirred for 40 min.
The solution was filtered through Celite, the DCM removed
in vacuo, and the dark residue extracted with THF (4 × 5 mL).
The combined extracts were put under vacuum until ca. 5 mL
remained, and the product was precipitated by the addition
of 10 mL of ether. The solvent was decanted off and the solid
washed twice with 10 mL of ether. The crude product was then
taken up in 3 mL of DCM and precipitated by vapor diffusion
of ether to yield deep red analytically pure crystals. Yield
(crude): 61 mg (53%). Anal. Calcd for C14H24N4Br2Pd: C, 32.68;
H, 4.70; N, 10.89. Found: C, 32.60; H, 4.48; N, 10.70. MS
(LSIMS; m/z): 513, [MH]+ (1.4%); 433, [M - Br]+ (17%); 354,
1
[Pd(tmiy)2]+ (4%); 125, [tmiyH]+ (100%). H NMR (400 MHz,
CD2Cl2): δ 3.85 (s, 12H, NCH3), 2.09 (s, 12H, CCH3). 13C NMR
(100 MHz, CD2Cl2): δ 157.4 (NCN), 125.7 (CdC), 35.4 (NCH3),
8.6 (CCH3).
1
identified by comparison to the spectra (MS, H/13C NMR) of
an authentic sample prepared by oxidative addition of I2 to 2
Ni(tm iy)2(o-tolyl)Br (8). To a THF (20 mL, -70 °C)
solution of Ni(COD)2 (342 mg, 1.24 mmol) was added a solution
of tmiy (315 mg, 2.54 mmol) in 20 mL of THF. After the
mixture was warmed to ambient temperature, o-tolyl bromide
(0.15 mL, 1.25 mmol) was syringed in and the solution stirred
for 1 h. The solution was filtered through Celite to yield a
homogeneous orange solution, from which the THF was
removed in vacuo until ca. 10 mL remained. The product was
precipitated by the addition of 15 mL of hexane, the solvent
decanted off, and the solid washed with hexane (25 mL) to
yield an orange powder after drying in vacuo. Crystals suitable
for X-ray analysis were grown by vapor diffusion of hexane
into a THF solution of the complex. Yield: 420 mg (71%). Anal.
Calcd for C21H31N4BrNi: C, 52.76; H, 6.54; N, 11.72. Found:
C, 52.53; H, 6.54; N, 11.65. MS (LSIMS; m/z): 397, [M - Br]+
(86%); 306, [Ni(tmiy)2]+ (93%); 215, [tmiy + tolyl]+ (100%); 182,
[Ni(tmiy)]+ (45%); 125, [tmiyH]+ (97%). 1H NMR (400 MHz,
DMSO-d6, 60 °C): δ 7.50 (s, br, 1H, Ph H), 6.49 (d, J ) 7 Hz,
2H, Ph H), 6.43 (d, J ) 7 Hz, 1H, Ph H), 4.05 (s, 12H, NCH3),
2.61 (s, 3H, PhCH3), 2.00 (s, 12H, CCH3). 13C NMR (50 MHz,
CDCl3): δ 180.2 (NCN), 156.0, 143.3, 138.4, 126.8, 122.3, 121.0
(PhC), 124.6 (CdCtmiy), 35.8 (NCH3), 26.2 (PhCH3), 9.4 (CCH3).
Rea ction of Ni(tm iy)2 a n d Meth yl Iod id e. In a typical
experiment tmiy (168 mg, 1.35 mmol) in 20 mL of THF was
added to Ni(COD)2 (182 mg, 0.662 mmol) dissolved in 20 mL
of THF (-60 °C) and the solution warmed to ambient tem-
perature. The solution was then cooled again (-60 °C) and
methyl iodide (43 µL, 0.69 mmol) syringed in. After it was
stirred for 20 min at -40 °C, the solution was filtered through
Celite and the solvent removed in vacuo until ca. 10 mL
remained. Hexane (20 mL) was added to precipitate the
product, and the solvent was decanted off. The solid was
(vide infra). MS (LSIMS of imidazolium salt; m/z): 201 [M]+
1
(100%). H NMR (400 MHz, DMSO-d6): δ 7.67 (t, J ) 7 Hz,
2H, Ph H), 7.47 (t, J ) 7 Hz, 2H, Ph H), 7.03 (d, J ) 7 Hz, 1H,
Ph H), 3.68 (s, 6H, NCH3), 2.04 (s, 6H, CCH3). GC-MS of the
reaction solution showed peaks due to biphenyl (m/z 154) and
2-phenyl-1,4,5-trimethylimidazole (m/z 185) resulting from
pyrolysis of the imidazolium salt on the heated injector/column.
P d (tm iy)2I2 (5). To a solution (0 °C) of Pd(tmiy)2(MAH) (54
mg, 0.12 mmol) in 5 mL of DCM was added dropwise over 1 h
a DCM solution (10 mL) of iodine (35 mg, 0.14 mmol). The
orange solution was filtered through Celite and washed
through with 5 mL of DCM. The solvent was removed in vacuo
and the residue washed with DCM/ether (2 mL/6 mL) and
further with ether (2 × 10 mL) before drying in vacuo to afford
an orange powder. Yield: 70 mg (96%). Anal. Calcd for
C14H24N4I2Pd‚0.5DCM (indicated by NMR): C, 26.75; H, 3.87;
N, 8.61. Found: C, 26.88; H, 3.58; N, 8.14. MS (LSIMS; m/z):
607, mixed cluster [M]+ and [M - I + tmiy]+ (17%); 481, [M -
1
I]+ (100%); 354, [M - 2I]+ (50%). H NMR (200 MHz, DMSO-
d6): δ 3.75 (s, 12H, NCH3), 2.07 (s, 12H, CCH3). 13C NMR (50
MHz, DMSO-d6): δ 158.9 (NCN), 126.1 (CdC), 35.9 (NCH3),
8.8 (CCH3).
P d (tm iy)2(4-n itr op h en yl)I (6). A DCM solution (10 mL)
of Pd(tmiy)2(MAH) (68 mg, 0.15 mmol) and 4-iodonitrobenzene
(43 mg, 0.17 mmol) was stirred at ambient temperature for 3
h, during which time the solution changes from dark red to a
lighter orange-red. The solution was filtered through Celite
and washed through with 5 mL of DCM and the solvent
removed in vacuo until ca. 2 mL remained. Acetone (5 mL)
was added and the solvent removed in vacuo until a precipitate
began to form, at which point 5 mL of ether was added to